[go: up one dir, main page]

NO931139L - Synergisme til tnf og il-4 - Google Patents

Synergisme til tnf og il-4

Info

Publication number
NO931139L
NO931139L NO93931139A NO931139A NO931139L NO 931139 L NO931139 L NO 931139L NO 93931139 A NO93931139 A NO 93931139A NO 931139 A NO931139 A NO 931139A NO 931139 L NO931139 L NO 931139L
Authority
NO
Norway
Prior art keywords
tnf
cells
composition
growth
human
Prior art date
Application number
NO93931139A
Other languages
English (en)
Norwegian (no)
Other versions
NO931139D0 (no
Inventor
Bharat Aggarwal
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO931139D0 publication Critical patent/NO931139D0/no
Publication of NO931139L publication Critical patent/NO931139L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Output Control And Ontrol Of Special Type Engine (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
NO93931139A 1990-10-01 1993-03-26 Synergisme til tnf og il-4 NO931139L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59097790A 1990-10-01 1990-10-01
PCT/US1991/007234 WO1992005805A1 (fr) 1990-10-01 1991-10-01 Synergie de tnf et il-4

Publications (2)

Publication Number Publication Date
NO931139D0 NO931139D0 (no) 1993-03-26
NO931139L true NO931139L (no) 1993-05-05

Family

ID=24364509

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931139A NO931139L (no) 1990-10-01 1993-03-26 Synergisme til tnf og il-4

Country Status (21)

Country Link
EP (1) EP0563060B1 (fr)
JP (1) JP3226918B2 (fr)
KR (1) KR100225322B1 (fr)
CN (1) CN1053838C (fr)
AT (1) ATE179617T1 (fr)
AU (1) AU658588B2 (fr)
CA (1) CA2092914C (fr)
DE (1) DE69131202T2 (fr)
DK (1) DK0563060T3 (fr)
ES (1) ES2134200T3 (fr)
FI (1) FI931426A7 (fr)
GR (1) GR3030930T3 (fr)
IE (1) IE913264A1 (fr)
IL (1) IL99497A (fr)
NO (1) NO931139L (fr)
NZ (1) NZ239829A (fr)
PT (1) PT99123B (fr)
RU (1) RU2114633C1 (fr)
SA (1) SA92120509B1 (fr)
WO (1) WO1992005805A1 (fr)
ZA (1) ZA917424B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1299295A (en) * 1993-12-02 1995-06-19 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
CN1100566C (zh) * 1998-08-26 2003-02-05 北京师范大学 含有钙调神经磷酸酶b亚基的药物组合物
ID30176A (id) * 1999-03-12 2001-11-08 Boehringer Ingelheim Pharma Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
UA71952C2 (en) * 1999-11-16 2005-01-17 Urea aromatic derivatives as antiinflammatory agents
RU2191586C1 (ru) * 2001-05-15 2002-10-27 Ростовский научно-исследовательский онкологический институт Способ лечения рака яичников
RU2201762C1 (ru) * 2001-10-09 2003-04-10 Свадовский Александр Игоревич Способ лечения внутримозговой опухоли головного мозга
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
RU2389502C2 (ru) * 2004-07-29 2010-05-20 Займодженетикс, Инк. Применение il-28 и il-29 для лечения карциномы и аутоиммунных нарушений
CN100482683C (zh) * 2005-06-09 2009-04-29 中国人民解放军军事医学科学院放射与辐射医学研究所 人富含甘氨酸蛋白的活性片段及其应用
CN113368219B (zh) * 2021-06-28 2024-05-10 广东工业大学 Globulol的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4770995A (en) 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides

Also Published As

Publication number Publication date
CA2092914A1 (fr) 1992-04-02
IL99497A0 (en) 1992-08-18
CN1053838C (zh) 2000-06-28
JPH06501704A (ja) 1994-02-24
WO1992005805A1 (fr) 1992-04-16
CN1060788A (zh) 1992-05-06
AU658588B2 (en) 1995-04-27
EP0563060B1 (fr) 1999-05-06
NO931139D0 (no) 1993-03-26
DE69131202D1 (de) 1999-06-10
GR3030930T3 (en) 1999-11-30
AU8950891A (en) 1992-04-28
DE69131202T2 (de) 2000-01-05
SA92120509B1 (ar) 2005-11-23
FI931426L (fi) 1993-04-27
ES2134200T3 (es) 1999-10-01
NZ239829A (en) 1993-03-26
EP0563060A4 (fr) 1993-08-04
JP3226918B2 (ja) 2001-11-12
CA2092914C (fr) 2002-12-03
FI931426A7 (fi) 1993-04-27
RU2114633C1 (ru) 1998-07-10
DK0563060T3 (da) 1999-11-08
PT99123B (pt) 1999-02-26
FI931426A0 (fi) 1993-03-30
EP0563060A1 (fr) 1993-10-06
PT99123A (pt) 1992-08-31
IL99497A (en) 1997-03-18
KR100225322B1 (ko) 1999-10-15
IE913264A1 (en) 1992-04-08
ATE179617T1 (de) 1999-05-15
ZA917424B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
NO931139L (no) Synergisme til tnf og il-4
AU593212B2 (en) Synergistic mixtures of interferons and tumor necrosis factor
DE3667946D1 (de) Tisch zum fixieren am ruecken eines sessels.
IL98070A0 (en) Muteins of the granulocyte colony stimulating factor(g-csf)and pharmaceutical compositions containing them
PL328003A1 (en) Modulation of cytokin th 1/th 2 expression by means of ribavirin and ribavirin analoques in t lymphocytes
NZ273258A (en) Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
RU93032615A (ru) Композиции для воздействия на опухолевые клетки, способ обработки опухолевых клеток
DE3479290D1 (en) Synergistic composition comprising gamma interferon and lymphotoxin, and its preparation
CA1265818C (fr) Fluoroallylamines non aromatiques inhibiteurs de la mao
GR3002779T3 (en) Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
HU9201197D0 (en) Protection from shock subsequent to injury by double-stranded rns
EP0017867A3 (en) Pharmaceutical preparation stimulating the proliferation of liver cells, and liver protecting and growth factor
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler
AU2605684A (en) Pyrethroid pharmaceutical composition
DE60308917D1 (de) Verwendung einer Zusammensetzung enthaltend 5-Androsten-3beta,17alpha-diol
杨贵贞 et al. EFFECTS OF GINSENOSIDE ON THE NATURAL KILLER CELL-INTERFERON-INTERLEUKIN-2 REGULATORY NETWORK AND ITS TUMOR INHIBITING EFFECT
KHOKHLOV et al. Changes in the ATP content and the surface adhesion in cultured human cells irradiated by lasers rays in the near-UV range(Izmenenie soderzhaniia ATF i poverkhnostno-adgezivnykh svoistv kletok cheloveka v kul'ture pod vozdeistviem lazernogo izlucheniia v blizhnei UF-oblasti spektra)
MY100308A (en) Fungicides containing triazole and oligoether groups and combinations
IT7800573V0 (it) Banco scolastico o da studio corredato di sedia entrambi regolabili in altezza
IT1157428B (it) Supporto estensibile per sedie, poltroncine, tavoli e simili